Hydroxylase enzymes of the vitamin D pathway: Expression, function, and regulation

Annual Review of Nutrition

Volumn 22, Issue , 2002, Pages 139-166

  Omdahl, John L ^a   Morris, Howard A ^a   May, Brian K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Calcium; Genetic diseases; P450; Phosphate; Steroid hormones

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITONIN; CALCITRIOL; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; HYPOPHYSIS HORMONE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; OXYGENASE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; PROTEIN KINASE C; RETINOID X RECEPTOR; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; CALCIUM HOMEOSTASIS; CANCER; CELL DIFFERENTIATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENOMICS; IMMUNE RESPONSE; INTESTINE; MACROPHAGE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW;

CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; MIXED FUNCTION OXYGENASES; SECOSTEROIDS; STEROID HYDROXYLASES; TRANSCRIPTION, GENETIC; VITAMIN D;

ANIMALIA;

EID: 0036403421     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.22.120501.150216     Document Type: Review

References (155)

1. 3. Proc. Natl. Acad. Sci. USA 78:4990-94
2. 3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 72:1856-60
3. 3. Endocrinology 138:2233-40
4. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, et al. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25:144-46
5. 3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell Biol. 15:5789-99
6. Andersson S, Davis DL, Dahlback H, Jomvall H, Russell DW. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222-29
7. 3 - Role of protein kinase C. J. Endocrinol. 169:145-51
8. Armbrecht HJ, Chen ML, Hodam TL, Boltz MA. 1997. Induction of 24-hydroxylase cytochrome P450 mRNA by 1,25-dihydroxyvitamin D and phorbol esters in normal rat kidney (NRK-52E) cells. J. Endocrinol. 153:199-205
9. 3. FEBS Lett. 327:13-16
10. 3 is regulated by parathyroid hormone in UMR106 osteoblastic cells. Endocrinology 139:3375-81
11. 3 is regulated by parathyroid hormone in UMR106 osteoblastic cells (see comments). Endocrinology 139: 3375-81
12. 3 1 alpha-hydroxylase activity. Biochem. Biophys. Res. Commun. 215:136-41
13. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 2001. 25-Hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression. Biochem. Biophys. Res. Commun. 285:1012-17
14. 3-24-hydroxylase, a multicatalytic enzyme. Biochemistry 35:8465-72
15. Bhattacharyya MH, DeLuca HF. 1973. The regulation of rat liver calciferol-25-hydroxylase. J. Biol. Chem. 248:2969-73
16. Bikle DD. 1982. The vitamin D endocrine system. Adv. Int. Med. 27:45-71
17. Bikle DD, Ng D, Tu C, Oda Y, Xie Z. 2001. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol. Cell Endocrinol. 177:161-71
18. Bjorkhem I, Moberg K. 1995. Inborn errors in bile acid biosynthesis and storage of steroids other than cholesterol. In The Metabolic Basis of Inherited Disease, ed. C Scriver, AL Beandet, W Sly, D Valk, pp. 2073-99. New York: McGraw-Hill
19. 3-1alpha-hydroxylase in a transformed human proximal tubule cell line: Evidence for direct regulation of vitamin D metabolism by calcium. Endocrinology 140:2027-34
20. Bland R, Zehnder D, Hughes SV, Ronco PM, Stewart PM, Hewison M. 2001. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int. 60:1277-86
21. 3), phospholipase D and protein kinase C in keratinocyte differentiation. Mol. Cell Endocrinol. 177:173-82
22. 3-1alpha-hydroxylase gene promoter. Proc. Natl. Acad. Sci. USA 95:1387-91
23. Bromberg JF. 2001. Activation of STAT proteins and growth control. Bioessays 23:161-69
24. Brown AJ, Dusso A, Slatopolsky E. 1999. Vitamin D. Am. J. Physiol. Renal Physiol. 277:F157-75
25. Burgos-Trinidad M, DeLuca HF. 1991. Kinetic properties of 25-hydroxyvitamin D- and 1,25-dihydroxyvitamin D-24-hydroxylase from chick kidney. Biochim. Biophys. Acta 1078:226-30
26. 3 is a positive regulator for the two antiencephalitogenic cytokines TGF-beta 1 and IL-4. J. Immunol. 160:5314-19
27. 3 analogues. Steroids 66:213-21
28. 3 analog and cyclosporine. Transplantation 65:1225-32
29. Chavez L, Harmeyer J, Choe S, Omdahl J. 2000. Molecular Basis of Pseudo Vitamin D Deficiency Rickets (PDDR) in the Hannover Pig Model. See Ref. 86a, pp. 175-78
30. 3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells. Endocrinology 132:1782-88
31. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 108:1083-86
32. 3-1(alpha)-hydroxylase gene (CYP27-B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 142:3135-41
33. DeLuca HF. 1997. Historical Overview. See Ref. 40a, pp. 3-11
34. Demers C, Lemay J, Hendy GN, Gascon-Barre M. 1997. Comparative in vivo expression of the calcitriol-24-hydroxylase gene in kidney and intestine. J. Mol. Endocrinol. 18:37-48
35. Dossing DA, Radeff JM, Sanders J, Lee S, Hsieh M, Stern PH. 2001. Parathyroid hormone stimulates translocation of protein kinase C isozymes in UMR-106 osteoblastic osteosarcoma cells. Bone 29:223-30
36. 3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J. Clin. Endocrinol. Metab. 82:2222-32
37. Dwivedi PP, Muscat GE, Bailey PJ, Omdahl JL, May BK. 1998. Repression of basal transcription by vitamin D receptor: Evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. J. Mol. Endocrinol. 20:327-35
38. 3-mediated induction. J. Biol. Chem. 275:47-55
39. 3 in vitamin D receptor-ablated mice in vivo. Biochemistry 39:2123-29
40. Erben R, Soegiarto D, Weber K, Zeitz U, Lieberherr M, et al. 2001. Deletion of DNA binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D and induces an atypical chronic myeloid leukemia-like disease in aged mice. J. Bone Miner. Res. 16:S229
41. a. Feldman D, Glorieux FH, Pike JW, eds. 1997. Vitamin D. San Diego: Academic
42. Friedman PA. 2000. Mechanisms of renal calcium transport. Exp. Nephrol. 8:343-50
43. Gallieni M, Kamimura S, Ahmed A, Bravo E, Delmez J, et al. 1995. Kinetics of monocyte 1 alpha-hydroxylase in renal failure. Am. J. Physiol. Renal Physiol. 268:F746-53
44. 3. J. Biol. Chem. 276:29148-56
45. Gay CV, Weber JA. 2000. Regulation of differentiated osteoclasts. Crit. Rev. Eukaryot. Gene Expr. 10:213-30
46. Graham SE, Peterson JA. 1999. How similar are P450s and what can their differences teach us? Arch. Biochem. Biophys. 369:24-29
47. 3 1 alpha-hydroxylase assayed by isotope dilution-mass spectrometry. Biochem. J. 250:521-26
48. Halloran BP, DeLuca HF. 1980. Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J. Nutr. 110:1573-80
49. 3 and its analogs on growth control and tumorigenesis. Front Biosci. 6:D820-48
50. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al. 1998. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J. Bone Miner. Res. 13:325-49
51. 3-24R-hydroxylase: A catabolic or biosynthetic enzyme? Steroids 66: 391-98
52. Hewison M, Zehnder D, Bland R, Stewart PM. 2000. 1alpha-hydroxylase and the action of vitamin D. J. Mol. Endocrinol. 25:141-48
53. Hoenderop JG, Hartog A, Stuiver M, Doucet A, Willems PH, Bindels RJ. 2000. Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine. J. Am. Soc. Nephrol. 11:1171-78
54. Holick MF. 1997. Photobiology of Vitamin D. See Ref. 40a, pp. 33-39
55. Hollis BW. 1997. Detection of vitamin D and its major metabolites. See Ref. 40a, pp. 587-606
56. 3 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J. Biol. Chem. 275:34650-55
57. 3-induced growth inhibition. Cancer Res. 61:2852-56
58. 3 24-hydroxylase in rat kidney. J. Histochem. Cytochem. 43:255-62
59. Johnson LE, DeLuca HF. 2001. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J. Nutr. 131:1787-91
60. Jones G, Strugnell SA, DeLuca HF. 1998. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78:1193-231
61. Deleted in proof
62. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275:18447-53
63. 3 metabolism in a pig strain with pseudo vitamin D-deficiency rickets, type I. Acta Endocrinol. 115:345-52
64. 3 24-hydroxylase (CYP24) promoter. J. Biol. Chem. 271:29715-21
65. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, et al. 2001. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am. J. Physiol. Renal Physiol. 280:F291-302
66. 3 1alphahydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation. J. Clin. Endocrinol. Metab. 84:4111-17
67. 3-1alpha-hydroxylase gene. Proc. Natl. Acad. Sci. USA 96:6988-93
68. 3 (calcitriol) in the human keratinocyte line HaCaT. Photochem. Photobiol. 72:803-9
69. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, et al. 1998. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391-96
70. Li YC, Pirro AE, Amling M, Delling G, Baron R, et al. 1997. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94:9831-35
71. Lian JB, Stein JL, Stein GS, Montecino M, van Wijnen AJ, et al. 2001. Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 66:159-70
72. Lipkin M, Newmark HL. 1999. Vitamin D, calcium and prevention of breast cancer: A review. J. Am. Coll. Nutr. 18:392S-97S
73. Lips P. 2001. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22:477-501
74. Lund EG, Guileyardo JM, Russell DW. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 96:7238-43
75. Malloy PJ, Pike JW, Feldman D. 1999. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 20:156-88
76. Marmorstein R, Roth SY. 2001. Histone acetyltransferases: Function, structure, and catalysis. Curr. Opin. Genet. Dev. 11: 155-61
77. Mayer J. 2001. Armand Trousseau and the arrow of time. Nutr. Rev. 15:321-23
78. 3 1α-hydroxylase gene expression in macrophages. Kidney Int. 58: 559-68
79. 31alpha-hydroxylase in nVDRE. J. Bone Miner. Res. 16:S229
80. 3. Biochem. Biophys. Res. Commun. 249: 11-16
81. 3 in intact animals. Endocrinology 140:2224-31
82. Naar AM, Lemon BD, Tjian R. 2001. Transcriptional coactivator complexes. Annu. Rev. Biochem. 70:475-501
83. Negrea L, Slatopolsky E, Dusso A. 1993. Lower affinity for substrate for extrarenal synthesis of calcitriol in chronic uremia. Kidney Int. 44:134-38
84. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, et al. 1996. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42
85. Nemere I, Farach-Carson MC. 1998. Membrane receptors for steroid hormones: A case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem. Biophys. Res. Commun. 248:443-49
86. 3 which mediates rapid activation of protein kinase C. J. Bone Miner. Res. 13:1353-59
87. 3: A Case Study of Transcaltachia (Rapid Hormonal Stimulation of Intestinal Calcium Transport). See Ref. 40a, pp. 233-56
88. a. Norman AW, Bouillon R, Thomasset M, eds. 2000. Vitamin D Endocrine System: Structure, Biological, Genetic and Clinical Aspects. Riverside: Univ. Calif.
89. 3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66: 147-58
90. 3 indicates that the 6-scis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Mol. Endocrinol. 11:1518-31
91. Oberste-Berghaus C, Zanger K, Hashimoto K, Cohen RN, Hollenberg AN, Wondisford FE. 2000. Thyroid hormone-independent interaction between the thyroid hormone receptor beta2 amino terminus and coactivators. J. Biol. Chem. 275:1787-92
92. 3 24-hydroxylase. FEBS Lett. 278:195-98
93. 3. J. Biol. Chem. 266: 8690-95
94. Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, May BK. 2001. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 66:381-89
95. Omdahl JL, May BK. 1997. The 25-hydroxyvitamin D 24-hydroxylase. See Ref. 40a, pp. 69-85
96. Onyango I, Hjalm G, Larsson M, Rask L. 1999. Effects of extracellular calcium on the subcellular translocation of bovine parathyroid PKC isozymes. Exp. Cell Res. 247:9-16
97. Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, et al. 2000. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 120:139-46
98. Palm T. 1890. The geographic distribution and etiology of rickets. Practitioner 45:270-79
99. Panda DK, Al Kawas S, Seldin MF, Hendy GN, Goltzman D. 2001. 25-Hydroxyvitamin D 1alpha-hydroxylase: Structure of the mouse gene, chromosomal assignment, and developmental expression. J. Bone Miner. Res. 16:46-56
100. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, et al. 2001. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 98:7498-503
101. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, et al. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 22:153-83
102. 3-treated or fasted guinea pigs. Biochem. J. 250:527-32
103. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2405-11
104. Pike JW. 1997. The Vitamin D Receptor and its Gene. See Ref. 40a, pp. 105-26
105. Pikuleva IA, Bjorkhem I, Waterman MR. 1997. Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27). Arch. Biochem. Biophys. 343:123-30
106. 3 receptor-corepressor partnership. FASEB J. 14:1455-63
107. Ponchon G, Kennan AL, DeLuca HF. 1969. "Activation" of vitamin D by the liver. J. Clin. Invest. 48:2032-37
108. 3 receptor: A network of coactivator interactions. Gene 246:9-21
109. Rachez C, Freedman LP. 2001. Mediator complexes and transcription. Curr. Opin. Cell Biol. 13:274-80
110. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, et al. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-28
111. 3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. Arch. Biochem. Biophys. 383:197-205
112. Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, et al. 1998. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 273: 14805-12
113. Russell J, Ashok S, Koszewski NJ. 1999. Vitamin D receptor interactions with the rat parathyroid hormone gene: Synergistic effects between two negative vitamin D response elements. J. Bone Miner. Res. 14:1828-37
114. Sakai Y, Kishimoto J, Demay MB. 2001. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J. Clin. Invest. 107:961-66
115. 3 to calcitroic acid. Eur J. Biochem. 262:43-48
116. 3 1alpha-hydroxylase coexpression with adrenodoxin and NADPH-adrenodoxin reductase in Escherichia coli. Eur. J. Biochem. 265:950-56
117. 3 by human CYF27A1. Biochem. Biophys. Res. Commun. 273:977-84
118. 3)-hydroxylases. Steroids 66:399-408
119. Schwartz GG. 1992. Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology 11:244-54
120. 3 in rat kidney but not in intestine. J. Biol. Chem. 267:13757-62
121. 3-1alpha-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 94:12920-25
122. 3-1alpha-hydroxylase gene in normocalcemic rats. Proc. Natl. Acad. Sci. USA 96:8253-58
123. Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T. 1999. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int. Suppl. 73:S2-7
124. 3 in promyelocytic NB4 leukemia cells: A structure-function study. Endocrinology 139:457-65
125. St Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, et al. 2000. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin droxyvitarnin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141:2658-66
126. St Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. 1997. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone Miner. Res 12:1552-59
127. Strewler GJ. 2001. FGF23, hypophosphatemia, and rickets: Has phosphatonin been found? Proc. Natl. Acad. Sci. USA 98: 5945-46
128. Sunn KL, Cock TA, Crofts LA, Eisman JA, Gardiner EM. 2001. Novel N-terminal variant of human VDR. Mol. Endocrinol. 15:1599-609
129. 3 1alpha-hydroxylase and vitamin D synthesis. Science 277:1827-30
130. Deleted in proof
131. 3. J. Bone Miner. Res. 16:57-62
132. Tenenhouse HS. 1999. Recent advances in epithelial sodium-coupled phosphate transport. Curr. Opin. Nephrol. Hypertens. 8:407-14
133. Tenenhouse HS, Martel J, Gauthier C, Zhang MY, Portale AA. 2001. Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate. Endocrinology 142:1124-29
134. 3-25-hydroxylase CYP27A. Am. J. Physiol. Endocrinol. Metab. 281:E315-25
135. Thomas GP, Baker SU, Eisman JA, Gardiner EM. 2001. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J. Endocrinol. 170:451-60
136. Tocchini-Valentini G, Rochel N, Wurtz JM, Mitschler A, Moras D. 2001. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. USA 98:5491-96
137. 3 Action in Human Osteoblast. See Ref. 86a, pp. 179-81
138. 3 and bone metabolism. Steroids 66:375-80
139. Vidal M, Dusso AS. 2001. Nuclear Interactions Between STATalpha and the Vitamin D Receptor Mediate the Inhibitory Effects of Gamma-interferon on 1alpha-dihydroxyvitamin D Action. See Ref. 86a, pp. 361-68
140. 3 in mouse osteoblasts. J. Bone Miner. Res. 16:S229
141. Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, et al. 1998. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 63:1694-702
142. 3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J. Bone Miner. Res. 4: 929-35
143. White P, Cooke N. 2000. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol. Metab. 11:320-27
144. Wikvall K. 2001. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int. J. Mol. Med. 7:201-9
145. Windaus A, Schenck F, von Werder F. 1936. Uber das antirachitisch wirksame bestrahlungs-produkt aus 7-dehydro-cholesterin. Hoppe-Seyler's Z. Physiol. Chem. 241:100-3
146. Wu S, Finch J, Zhong M, Slatopolsky E, Grieff M, Brown AJ. 1996. Expression of the renal 25-hydroxyvitamin D-24-hydroxylase gene: Regulation by dietary phosphate. Am. J. Physiol. Renal Physiol. 271:F203-8
147. 3 in UMR106 osteoblastic cells. Am. J. Physiol. Endocrinol. Metab. 281:E162-70
148. Yordy JS, Muise-Helmericks RC. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19:6503-13
149. 1 cells. J. Am. Soc. Nephrol. 10:2474-79
150. 3 1alpha-hydroxylase gene expression. Endocrinology 142:1720-26
151. 3-1α-hydroxylase in the human kidney. J. Am. Soc. Nephrol. 10:2465-73
152. 3-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 86:888-94
153. Zhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W, MacDonald PN. 2001. Ternary complexes and cooperative interplay between NCoA-62/SKIP and SRC coactivators in VDR-mediated transcription. J. Biol. Chem. 276:40614-20
154. Zierold C, Mings J, DeLuca H. 2001. PTH regulates 24-hydroxylase mRNA by altering its stability. J. Bone Miner. Res. 16: S556
155. 3 and parathyroid hormone in AOK-B50 cells. Arch. Biochem. Biophys. 381:323-27